De-escalating antiplatelet therapy to ticagrelor monotherapy appears to lower risk of bleeding in stented patients
In patients with ACS (acute coronary syndrome) who have undergone DES (drug-eluting stent) implantation, de-escalating DAPT (dual antiplatelet therapy) to ticagrelor monotherapy resulted in a lower risk for… read more.
